Jon P. Stonehouse

2011

In 2011, Jon P. Stonehouse earned a total compensation of $1.3M as President, Chief Executive Officer and Director at BioCryst Pharmaceuticals, a 5% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$219,383
Option Awards$465,360
Salary$459,617
Stock Awards$118,275
Other$13,655
Total$1,276,290

Stonehouse received $465.4K in option awards, accounting for 36% of the total pay in 2011.

Stonehouse also received $219.4K in non-equity incentive plan, $459.6K in salary, $118.3K in stock awards and $13.7K in other compensation.

Rankings

In 2011, Jon P. Stonehouse's compensation ranked 4,777th out of 10,747 executives tracked by ExecPay. In other words, Stonehouse earned more than 55.6% of executives.

ClassificationRankingPercentile
All
4,777
out of 10,747
56th
Division
Manufacturing
1,710
out of 3,960
57th
Major group
Chemicals And Allied Products
355
out of 1,033
66th
Industry group
Drugs
215
out of 781
73rd
Industry
Biological Products, Except Diagnostic Substances
35
out of 157
78th
Source: SEC filing on March 21, 2014.

Stonehouse's colleagues

We found five more compensation records of executives who worked with Jon P. Stonehouse at BioCryst Pharmaceuticals in 2011.

2011

Thomas Staab

BioCryst Pharmaceuticals

Chief Financial Officer

2011

William Sheridan

BioCryst Pharmaceuticals

Chief Medical Officer

2011

Yarlagadda Babu

BioCryst Pharmaceuticals

Senior Vice President of Drug Discovery

2011

David McCullough

BioCryst Pharmaceuticals

Vice President, Strategic Planning, Commercialization and Corporate Development

2011

Stuart Grant

BioCryst Pharmaceuticals

Chief Financial Officer

News

You may also like